Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 13, 2010, Pages 4793-4800

  Bremner, John B ^a   Keller, Paul A ^a   Pyne, Stephen G ^a   Boyle, Timothy P ^a   Brkic, Zinka ^a   Morgan, Jody ^a   Somphol, Kittiya ^a   Coates, Jonathan A ^b   Deadman, John ^b   Rhodes, David I ^b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b Avexa Ltd   (Australia)

Author keywords

Antibacterial; Binaphthyl; Cationic peptides; Tripetoid

Indexed keywords

2 [2' (ISOPENTYLOXY)BIPHENYL 2 YLOXY]ACETIC ACID; 2' (ISOPENTYLOXY)BIPHENYL 2 OL; 6 (TERT BUTOXYCARBONYLAMINO) 2 [2 [2' (ISOPENTYLOXY)BIPHENYL 2 YLOXY]ACETAMIDO]HEXANOATE; BENZYL 2 ALLYL 3,6,9 TRIAZA 11 [2 (2' BENZYLOXY 1,1' BINAPHTHALEN 2 YLOXY)] 8 (BUTYLAMINO) 5 (3 GUANIDINOPROPYL) 4,7,10 TRIOXOUNDECANOATE; BENZYL 2 ALLYL 3,6,9 TRIAZA 8 (4 AMINOBUTYL) 5 (3 GUANIDINOPROPYL) 4,7,10 TRIOXO 2 PROPYL 11 [2 (2' BENZYLOXY 1,1' BINAPHTHALEN 2 YLOXY)] 8 (BUTYLAMINO) 5 (3 GUANIDINOPROPYL) 4,7,10 TRIOXOUNDECANOATE; METHYL 6 (TERT BUTOXYCARBONYLAMINO) 2 [2 [2' (ISOPENTYLOXY)BIPHENYL 2 YLOXY]ACETAMIDO]HEXANOATE; NAPHTHYL GROUP; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PEPTOIDS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

STAPHYLOCOCCUS AUREUS;

EID: 77954214959     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.05.005     Document Type: Article

References (14)

1. Bremner, J. B.; Keller, P. A.; Pyne, S. G.; Boyle, T. P.; Brkic, Z.; David, D. M.; Robertson, M.; Somphol, K.; Baylis, D.; Coates, J. A.; Deadman, J.; Jeevarajah, D.; Rhodes, D. I. Bioorg. Med. Chem. 2010, in press (doi:10.1016/j.bmc.2010.02.033 ).
2. P. Nordmann, T. Naas, N. Fortineau, and L. Poirel Curr. Opin. Microbiol. 10 2007 436
3. K.C. Nicolaou, and C.N.C. Boddy Sci. Am. 284 2001 54
4. W.C. Noble, Z. Virani, and R.G.A. Cree FEMS Microbiol. Lett. 93 1992 195
5. D. Kahne, C. Leimkuhler, W. Lu, and C. Walsh Chem. Rev. 105 2005 425
6. P.C. Appelbaum Clin. Microbiol. Infect. 12 2006 16
7. L.B. Rice Am. J. Med. 119 2006 S11
8. G.D. Wright, and A.D. Sutherland Trends Mol. Med. 13 2007 260
9. J.B. Bremner, P.A. Keller, S.G. Pyne, T.P. Boyle, Z. Brkic, D.M. David, J. Morgan, M. Robertson, K. Somphol, M.H. Miller, A.H. Howe, P. Ambrose, S. Bhavnani, T.R. Fritsche, D.J. Biedenbach, R.N. Jones, R.W. Buckheit Jr., K.M. Watson, D. Baylis, J.A. Coates, J. Deadman, D. Jeevarajah, A. McCracken, and D.I. Rhodes Angew. Chem., Int. Ed. 49 2010 537
10. For work on other cationic peptides and a pharmacophore model see: M.B. Strom, B.E. Haug, M.L. Skar, W. Stensen, T. Stiberg, and J.S. Svendsen J. Med. Chem. 46 2003 1567
11. B.E. Haug, W. Stensen, T. Stiberg, and J.S. Svendsen J. Med. Chem. 47 2004 4159
12. B.E. Haug, W. Stensen, and J.S. Svendsen Bioorg. Med. Chem. Lett. 17 2007 2361
13. B.E. Haug, W. Stensen, M. Kalaaji, O. Rekdal, and J.S. Svendsen J. Med. Chem. 51 2008 4306
14. K. Flemming, C. Klingenberg, J.P. Cavanagh, M. Sletteng, W. Stensen, J.S. Svendsen, and T. Flaegstad J. Antimicrob. Chemother. 63 2009 136